|
Please click on the respective TB-NET # to see details of the respective projects.
TB-NET #1 TIGRA in Immunocompromised PatientS (TIPS)
Principal Investigator: Martina Sester (Germany)
This project has lead to one large and well designed multicenter trial on the performance of IGRA in patients with immunosuppression. A protocol has been approved and will be followed at different TBNET centers in Europe.
|
| |
TB-NET #2 Use of IGRA testing in TB contact tracing: database supported analysis
Principal investigator: Jean Pierre Zellweger (Switzerland), Roland Diel (Germany)
Based on the experience with the Swiss database, this study will compare the performance of MTB-specific IGRA in contact tracing in different European countries. This study will yield information on the actual number of persons infected with MTB who will develop subsequently tuberculosis, allowing a more precise estimate of the breakdown rate. |
| |
TB-NET #16 A database for paediatric tuberculosis in Europe
Principal investigator: Beate Kampmann (UK) |
| |
TB-NET #17 The negative prospective value of IGRA for the diagnosis of latent TB in children in Europe
Principal investigator: Beate Kampmann (UK) |
| |
TB-NET #18 TB patients' perceptions of their illness by implementation of the Brief Illness Perception Questionnaire (BIPQ)
Principal investigator: Dragica Pesut (Serbia) |
| |
TB-NET #19 A multinational case-control study on predisposing host and environmental factors for infections with nontuberculous mycobycteria (NTM)
Principal Investigator: Dirk Wagner (Germany) |
| |
TB-NET #20 Differentiation profile of antigen-specific T-cells in M.tuberculosis
Principal investigator: Delia Goletti (Italy) |
| |
TB-NET #21 Rates of TB in european capital cities from low incidence countries
Principal investigator: Graham Bothamley (UK) |
| |
TB-NET #22 Evaluation of non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Principal Investigator: Josè Dominguez (Spain) |
| |
TB-NET #23 FIAT 500 study (False negative Igra results in Active Tuberculosis
Principal Investigator: Aik Bossink (The Netherlands) |
|
